Companies: 10,795·Total market cap: $144.5T
Merck KGaA

Merck KGaA

MKGAFOTCHealthcare● Active
$155.09
$-8.69(-5.31%)
Market Cap$67.4B
P/E Ratio
52W High$163.85
52W Low$116.68
Overview

Merck KGaA(MKGAF)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MKGAF · 截至 Jun 8, 2026

关键指标

EPS (TTM)$5.82mkgaf eps ttm · mkgaf earnings per shareEarnings history
PE Ratio (TTM)26.6×mkgaf pe ratio ttm · mkgaf price to earningsPE Ratio deep dive
Revenue (TTM)$21.0Bmkgaf revenue ttm · mkgaf annual revenueFull revenue history
Dividend Yield1.93%does mkgaf pay dividends · mkgaf dividend yieldDividend history
Shares Outstanding434.8Mmkgaf shares outstanding · mkgaf floatShares outstanding history
Next EarningsAug 6, 2026Est.mkgaf earnings date · mkgaf next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$21.09B▼ 0.29% YoY
202320242025
merck kgaa revenue · mkgaf revenue 2025
FY 2025Net Income$2.61B▼ 6.12% YoY
202320242025
merck kgaa net income · mkgaf profit 2025
FY 2025EPS$6.00▼ 6.10% YoY
202320242025
mkgaf eps · merck kgaa earnings per share 2025
TTM:Revenue: $20.97BNet Income: $2.54BEPS: $5.82View income statement →

股票表现

完整历史
1D-5.31%
1W-3.81%
1M+15.55%
3M+19.80%
YTD+5.07%
1Y+13.47%
5Y-18.48%

关于 Merck KGaA

CEOBelen Garijo Lopez
IPO DateAug 3, 2012
Employees59,020
CountryDE

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, …

what is merck kgaa · mkgaf stock overview · merck kgaa company profile · who is merck kgaa ceo · mkgaf OTC · merck kgaa headquarters · merck kgaa business segments

关于股票概览与关键数据

Merck KGaA(MKGAF)是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司,于 Aug 3, 2012 在 OTC 上市。截至最近交易日,MKGAF 股价为 $155.09,市值约为 $67.4B。过去12个月累计回报 +13.47%,年初至今回报 +5.07%。

2025 财年 Merck KGaA 营收 $21.1B。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Merck KGaA(MKGAF)股价为 $155.09,在 OTC 上市,52周区间为 $116.68 – $163.85。

MKGAF 最新股价MKGAF quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议